
Fernanda Bertasi
business executiveFemale0.0Global Dominance: 0.00%
Fernanda Bertasi is the General Manager of Pint Pharma in Brazil. She has been instrumental in advocating for patient care and improving access to innovative treatments, particularly for conditions such as Polycythemia Vera. Under her leadership, the approval of BESREMi® by ANVISA represents a significant advancement for patients in Brazil.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Fernanda Bertasi, General Manager of Pint Pharma in Brazil, stated that the approval of BESREMi® represents a transformative milestone for patients with Polycythemia Vera in Brazil.
Pint Pharma Anuncia la Aprobación de BESREMi® (ropeginterferón alfa-2b) por parte de ANVISA para el Tratamiento de la Policitemia VeraEl Nacional·
Venezuela· 2025-03-21



